VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares were down 14.7% on Wednesday . The stock traded as low as C$0.15 and last traded at C$0.15. Approximately 266,015 shares changed hands during trading, a decline of 10% from the average daily volume of 294,436 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Performance
The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The firm’s 50-day moving average is C$0.11 and its two-hundred day moving average is C$0.13. The stock has a market cap of C$24.33 million, a P/E ratio of -4.63 and a beta of 0.39.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- Expert Stock Trading Psychology Tips
- 3 Undervalued Stocks You Can Buy at a Discount Now
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
